DIABETIC RANGE

Product Details:

Glimepiride (1mg) & Metformin SR (1000mg)
gLIMITERIS

Glimepiride (1mg) and Metformin SR (1000mg) refer to a combination of two oral medications used to treat type 2 diabetes.

• Glimepiride (1mg): This is a sulfonylurea class medication that helps increase insulin secretion from the pancreas, which helps lower blood sugar levels. The 1mg dosage indicates the amount of glimepiride in the medication.

• Metformin SR (1000mg): "SR" stands for sustained release. Metformin is a biguanide class medication that helps reduce glucose production in the liver, increases insulin sensitivity, and enhances glucose uptake by the muscles. The sustained release form (1000mg) slowly releases the medication into the body, which helps maintain a steady level of the drug in the bloodstream and minimizes side effects.

Together, these medications work in different ways to help control blood sugar levels in individuals with type 2 diabetes, improving glycemic control and reducing the risk of diabetes-related complications.

Product Details:

Glimepiride (2mg) & Metformin SR (1000mg)

GLIMITERIS

Glimepiride (2mg) and Metformin SR (1000mg) represent a combination therapy used for managing type 2 diabetes:

• Glimepiride (2mg): This is a medication belonging to the class of drugs known as sulfonylureas. It works by stimulating the pancreas to release more insulin, thus helping to lower blood sugar levels. The 2mg dosage indicates the amount of glimepiride in each tablet.

• Metformin SR (1000mg): Metformin is a biguanide class drug that helps control blood sugar levels. "SR" stands for sustained release, meaning that the drug is released gradually over time to provide a prolonged effect. Metformin works by decreasing the amount of sugar the liver releases into the blood and improving the body's sensitivity to insulin. The 1000mg dosage refers to the amount of metformin in the sustained release formulation.

This combination helps in effectively managing blood sugar levels over the day in patients with type 2 diabetes, improving glycemic control and reducing the risk of diabetes-related complications.

Product Details:

Glimepiride (2mg) & Metformin Hydrochloride (500mg) Prolonged Release
GLIMITERIS 

Glimepiride (2mg) and Metformin Hydrochloride (500mg) Prolonged Release refer to a combination of two medications used to treat type 2 diabetes:

• Glimepiride (2mg): A sulfonylurea drug that helps increase insulin release from the pancreas, thereby lowering blood sugar levels. The 2mg indicates the amount of glimepiride per tablet.

• Metformin Hydrochloride (500mg) Prolonged Release: Metformin is a biguanide class medication that helps control blood sugar levels primarily by reducing glucose production in the liver and improving insulin sensitivity. The term "Prolonged Release" means the medication is formulated to release the active substance slowly over time, which can help maintain stable blood sugar levels and minimize side effects. The 500mg specifies the amount of metformin hydrochloride in each prolonged-release tablet.

This combination therapy is effective in managing blood glucose levels in patients with type 2 diabetes, offering the benefits of both medications while potentially reducing the risk of side effects associated with higher doses of either medication alone.

Product Details:

At Steris Healthcare, we understand the critical role that medicines and drugs play in promoting wellness, treating illnesses, and enhancing the quality of life. Our comprehensive portfolio encompasses various therapeutic areas, including but not limited to cardiology, neurology, oncology, infectious diseases, respiratory health, and many more. Whether it's life-saving medications or specialized treatments, we strive to deliver innovative and effective solutions to meet the diverse needs of healthcare providers and patients worldwide.

Product Details:

Linagliptin 5mg and Metformin Hydrochloride (SR) 500mgLINALIGLIP M 5/500  Linagliptin is an oral medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor.Its primary mode of action is to increase the levels of incretin hormones in the body, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP).By inhibiting the enzyme DPP-4, linagliptin prolongs the activity of these hormones, which stimulate the release of insulin and inhibit the production of glucagon. This results in improved blood sugar control after meals.Metformin is one of the most commonly prescribed oral medications for type 2 diabetes.It belongs to the biguanide class of drugs and works by decreasing the amount of glucose produced by the liver and improving the body's sensitivity to insulin.Metformin also helps reduce the absorption of glucose from the intestines and may have other beneficial effects on metabolism

Product Details:

Glimipiride 2 mg + Metformin SR 500 + Pioglitazone 15 mg

Seizmet GP 2 is a combination of three antidiabetic medicines. Seizmet GP 2 works by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective.Seizmet GP 2 is a sulfonylurea that works by increasing the amount of insulin released by the pancreas in order to lower blood glucose. Seizmet GP 2 works by lowering glucose production in the liver, delaying glucose absorption from the intestines, and increasing the body's sensitivity to insulin.

 

Product Details:

Linagliptin 
LINALIGLIP 2.5  is an oral medication used for the management of type 2 diabetes mellitus. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Here's some key information about LINALIGLIP 2.5 :
Type 2 diabetes treatment: LINALIGLIP 2.5  is primarily prescribed to lower blood sugar levels in adults with type 2 diabetes. It is used as an adjunct to diet and exercise, and it may be prescribed alone or in combination with other antidiabetic medications.
Mechanism of action: LINALIGLIP 2.5  works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4). This enzyme breaks down incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By inhibiting DPP-4, LINALIGLIP 2.5  increases the levels of these hormones, which helps stimulate the release of insulin and reduce the production of glucose by the liver.
Dosage and administration: The usual recommended dose of LINALIGLIP 2.5  is 5 mg taken orally once daily. It can be taken with or without food. The dosage may be adjusted based on individual patient needs and in combination with other antidiabetic medications.
Effectiveness: LINALIGLIP 2.5  has been shown to effectively lower blood sugar levels in patients with type 2 diabetes. It helps improve glycemic control, but its efficacy may vary among individuals. Regular monitoring of blood sugar levels is important to assess the response to treatment.
Side effects: Common side effects of LINALIGLIP 2.5  are generally mild and include upper respiratory tract infections, runny or stuffy nose, sore throat, and headache. Hypoglycemia (low blood sugar) is rare when LINALIGLIP 2.5  is used as a monotherapy but may occur when combined with other antidiabetic medications.
Precautions and contraindications: LINALIGLIP 2.5  should be used with caution in individuals with a history of pancreatitis or with severe kidney impairment. LINALIGLIP 2.5  is generally well-tolerated, but rare cases of hypersensitivity reactions have been reported. It is important to inform the prescribing doctor about any pre-existing medical conditions and all medications being taken.
Special populations: LINALIGLIP 2.5  is generally well-tolerated in older adults and does not require dosage adjustments based on age. It can be used in patients with mild to moderate renal impairment without dose adjustment.

Product Details:

Gliclazide 80mg
gliiclazide 80
gliclazide 80 belongs to a class of medications called sulfonylureas. gliiclazide 80 helps lower blood sugar levels by stimulating the pancreas to release more insulin and by increasing the sensitivity of cells to The typical starting dose of Gliclazide is 80mg taken orally once daily with breakfast or the first main meal of the day. However, the dosage may vary based on individual needs and response to treatment. Your healthcare provider will determine the appropriate dose for you.Gliclazide is usually prescribed as part of a comprehensive treatment plan for type 2 diabetes, which may include dietary changes, exercise, and other med iications. Regular monitoring of blood sugar levels is important while taking Gliclazide to ensuret is effectively controlling diabetes without causing low blood sugar (hypoglycemia) or other adverse effects.gliiclazide 80 essential to follow your doctor's instructions carefully when taking Gliclazide. Inform your healthcare provider about any other medications, supplements, or medical conditions you have, as they may interact with Gliclazide.Common side effects of Gliclazide may include hypoglycemia (low blood sugar), gastrointestinal disturbances, dizziness, and skin reactions. Contact your doctor if you experience any concerning side effects.

Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.